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The present work explored the antinociceptive effects of the ﬂavonoid myricitrin in models of overt
nociception triggered by intraplantar injection of chemical algogens into the hind paw of mice. The
nociception induced by bradykinin (3nmol/paw i.pl.) was abolished by prior treatment with myricitrin
(10–100mg/kg, i.p.) with ID50 of 12.4 (8.5–18.1)mg/kg. In sharp contrast, myricitrin failed to affect the
nociception elicited by prostaglandin E2 (3nmol/paw i.pl.). Cinnamaldehyde (10nmol/paw i.pl.)-induced
nociception was reduced by myricitrin (100mg/kg, i.p.) and camphor (7.6mg/kg, s.c.) in 43±10% and
57±8%, respectively.Myricitrin (30–100mg/kg, i.p.) and amiloride (100mg/kg, i.p.) inhibitednociceptive
responses induced by acidiﬁed saline (pH 5/paw i.pl.), with ID50 of 22.0 (16.1–30.0)mg/kg and inhibition
of71±6%and64±5%, respectively.Moreover,myricitrin (10–30mg/kg, i.p.) and rutheniumred (3mg/kg,
i.p.) signiﬁcantly reduced the nociception induced by menthol (1.2mol/paw i.pl.) with the mean ID50
of 2.4 (1.5–3.7)mg/kg and inhibition of 95±3% and 51±7%, respectively. In addition, myricitrin admin-
istration (30 and 100mg/kg, i.p.) markedly reduced menthol-induced mechanical allodynia. However,
myricitrin (100mg/kg, i.p.) prevented (only in time of 60min) cold allodynia induced by menthol. Collec-
tively, the present results extend prior data and show that myricitrin promotes potent antinociception,
an action that is likely mediated by an inhibition of the activation of nociceptors by bradykinin and TRPs
agonist (i.e. cinnamaldehyde, acidiﬁed saline and menthol), probably via inhibition of PKC pathways.
Thus, myricitrin could constitute an attractive molecule of interest for the development of new analgesic
drugs.
cute nociceptive pain is the consequence of primary afferent noci-
eptive C and A ﬁbers activation by intense mechanical, chemical,
r thermal stimuli [18]. Thus, suchnoxious stimuli exciteperipheral
ociceptors by activation of distinct types of ionotropic channels
nd metabotropic receptors [18]. In fact, transient receptor poten-
ial (TRP) and acid-sensing ion channels (ASIC) play important
oles in generating nociceptive signals in response to various spe-
iﬁc noxious stimuli [10]. In addition, following tissue injury or
uring certain inﬂammatory processes occurs the release of pro-
nﬂammatory mediators, namely bradykinin, prostaglandins and
rotons that contribute to elicit nociceptive signals as well as to
romote hyperalgesia and allodynia [7,18]. Finally, the activity of
ome of these receptors can be facilitated (or upregulated) by pro-
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tein kinasesA andC (PKAandPKC),which sensitize themor amplify
their responses byphosphorylating key residues in their structures,
as well as of other proteins implicated in nociceptive signaling
pathways in sensory neurons [32,33].
Although a considerable number of antinociceptive drugs are
available, novel substances could contribute to our current under-
standing of the nociceptive signaling pathways to improve the
treatment of painful conditions. Many plant-derived substances
are attractive sources for developing new analgesic agents, among
these, myricitrin, a naturally occurring ﬂavonoid obtained from
genus Eugenia displays marked anti-inﬂammatory and antinoci-
ceptive effects in rodents [24–27]. Our group has shown that
myricitrin inhibited nociception caused by acetic acid and by intra-
Open access under the Elsevier OA license.plantar injection of glutamate, capsaicin and phorbol myristate
acetate (PMA) inmice [25]. In addition,myricitrin reducedmechan-
ical hyperalgesia induced by intraplantar injection of bradykinin
in rats as well as the inﬂammatory and neuropathic allodynia
caused by intraplantar injection of complete Freund’s adjuvant and
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y partial sciatic nerve ligation in mice [25,26]. Interestingly, the
echanisms involved in the antinociceptive action of myricitrin
nclude inhibitionof PKCandofp38MAPKphosphorylation [25,27].
Here, we evaluated the effect of myricitrin on nociception
riggered by intraplantar injection of bradykinin, prostaglandin
2, protons (activator of ASIC/TRPV1 channels), cinnamaldehyde
agonist of TRPA1 channel), menthol (agonist of TRPM8 channel).
inally, we evaluated the effect of myricitrin on cold and mechani-
al allodynia induced by intraplantar injection of menthol in mice.
Male Swiss mice (25–35g) were housed (22±2 ◦C, 12h
ight–dark cycle) with food and water ad libitum. Mice were
cclimatized to the laboratory for at least 1h before testing. All
xperiments were previously approved by the UFSC’s Committee
n the Ethical Use of Animals, and conducted under the ethical
uidelines of the International Association for the Study of Pain
42].
First, we investigated whether myricitrin would be able to
ntagonize bradykinin- and prostaglandin-induced nociception in
hemousepaw.Animalsusedwere individually adapted intoaglass
unnel. Myricitrin (1–100mg/kg, i.p.) or vehicle (control, 10ml/kg,
.p.) was administered 30min before intraplantar (i.pl.) injection
f the chemical algogens [12,19]. Following myricitrin or vehicle
reatment, mice received a 20l i.pl. injection of either bradykinin
3nmol/paw) or prostaglandin E2 (3nmol/paw). Immediately after
he injection, each animal was placed into individual glass cylinder
f 20 cm and paw licking or biting was measured for 15min, and
onsidered as indicative of nociception.
In another set of experiments, to test if TRPA1, TRPM8 and ASIC
eceptors constitute potential speciﬁc targets for the antinocicep-
ive actions of myricitrin, we tested the effects of this ﬂavonoid
gainst nociceptive responses elicited by activators of each chan-
el. To this effect, following treatment with myricitrin, camphor
7.6mg/kg, subcutaneous (s.c.) used as positive control], amiloride
100mg/kg, i.p. used as positive control), ruthenium red (3mg/kg,
.p. used as positive control) or vehicle, mice received a 20l intra-
lantar (i.pl.) injection of either cinnamaldehyde (10nmol/paw),
cidiﬁed saline (2% acetic acid in 0.9% saline, pH 5/paw) or men-
hol (1.2mol/paw). Paw licking or biting were recorded for 5min
for cinnamaldehyde), 15min (for acidiﬁed saline) or 20min (for
enthol).
Myricitrin (30mg/kg)was administered by i.p. route at different
imes (15–240min) before i.pl. injection of menthol to determine
he duration of its antinociceptive effect. Next, we examined the
nﬂuence of myricitrin (30 and 100mg/kg, i.p.) in menthol-induced
echanical and cold allodynia. For assessment, mice were placed
n clear plexiglas observation chambers (9 cm×7 cm×11 cm) on
levated wire mesh platforms. Animals were habituated to the
hamber for 30min. Hind paw responsiveness to mechanical or
old stimuli were assessed before menthol (1.2mol/paw) injec-
ion and then again, repeatedly, at several time points thereafter,
ut animals were exposed only to a single modality of sensory
timulus.
Mechanical allodyniawas evaluated as thewithdrawal response
requency to 10 applications of 0.4 g of von Frey hairs (Stoelting,
hicago, USA) [6]. Cold allodynia was assessed through spraying
0l of acetone on the plantar surface of the hind paw. Behavioral
esponse was analyzed during 20 s and then recorded in scores: 0
no response; 1 – quick withdrawal, ﬂick or stamp of the paw; 2 –
rolongedwithdrawal or repeated ﬂicking of the paw; 3 – repeated
icking of the paw with licking directed at the ventral side of the
aw. Acetone application was repeated three times for each hind
aw, in 5min intervals, and the sum of three scores was used for
ata analysis [13].
The following substances were used: myricitrin was isolated
rom the plant of genus Eugenia in the Department of Chemistry,
ederal University of Santa Catarina, Brazil. Analysis of the 1H NMRLetters 495 (2011) 173–177
and 13C NMR spectra showed analytical and spectroscopic data in
full agreement with its assigned structure [1]. The chemical purity
of myricitrin (more than 98%) was determined by GC/HPLC. Myric-
itrin was dissolved in Tween 80 plus saline. The ﬁnal concentration
of Tween did not exceed 10% and did not cause any effect per se.
Bradykinin, prostaglandin E2, cinnamaldehyde,menthol amiloride,
camphor and ruthenium red were from Sigma–Aldrich (St. Louis,
MO).All other chemicalswereof analytical gradeandobtained from
standard commercial suppliers. Drugs were dissolved in 0.9% NaCl
solution, with the exception of menthol, which was dissolved in
1.6% ethanol/0.01% Tween 80 in saline. In both of these conditions,
the ﬁnal solutions containing ethanol failed to cause any nocicep-
tive effects per se when administered alone. All procedures, doses
and administration routes of the various drugs were chosen on the
basis of previous studies [3,4,12,19,23,36] or in preliminary exper-
iments carried out in our laboratory (data not shown).
Results are presented as mean± S.E.M., except the ID50 values
(i.e. the dose of myricitrin that reduce the nociceptive response by
50% relative to the control values), which are reported as geometric
means accompanied by their respective 95% conﬁdence limits. The
ID50 values were determined by nonlinear regression from indi-
vidual experiments using GraphPad software (GraphPad software,
San Diego, CA, USA). The percentages of inhibition were calculated
for the most effective dose used. Data concerning nociception to
chemical stimuliwere analyzed statistically using one-way ANOVA
followed by Newman–Keuls’ post hoc test. Statistical comparisons
of mechanical and cold allodynia data were performed by two-
way ANOVA, followed by Bonferroni’s multi-comparison post hoc
test. In all cases, differenceswere considered to be signiﬁcantwhen
P<0.05.
Myricitrin (3–100mg/kg, i.p.) produced dose-dependent inhibi-
tion (83±2%) of bradykinin-induced nociception with mean ID50
of 12.4 (8.5–18.1)mg/kg (Fig. 1A). Post hoc comparisons with
the Newman–Keuls test detected a signiﬁcant difference with
myricitrin treatment at doses of 10mg/kg (P<0.01), 30mg/kg
(P<0.001) and 100mg/kg (P<0.001). Like bradykinin, i.pl. injection
of prostaglandin E2 also induced nociceptive behaviors in mice.
However, myricitrin had no effect on nociceptive response trig-
gered by prostaglandin E2 (P>0.05) (Fig. 1B).
As shown in Fig. 1C, only the highest dose of myricitrin
(100mg/kg, i.p.) inhibited the nociceptive behavior induced by cin-
namaldehyde, with inhibition of 43±10% (P<0.001). Pretreatment
of camphor (7.6mg/kg, s.c.), a nonspeciﬁc TRPblocker, inhibited the
cinnamaldehyde-induced nociception in 57±8% (P<0.01). Fig. 1D
shows that myricitrin (1–100mg/kg, i.p. 30min before) also inhib-
ited (71±6%) the nociceptive response induced by acidiﬁed saline
with the mean ID50 value of 22.0 (16.1–30.0)mg/kg. Post hoc
comparisons with the Newman–Keuls test detected a signiﬁcant
difference with myricitrin at doses of 30mg/kg (P<0.001) and
100mg/kg (P<0.01). Moreover, the blocking of the acid-sensitive
ion channels (ASICs) by amiloride (100mg/kg, i.p.) also decreased
the nociception mediated by acidiﬁed saline in 64±5% (P<0.001).
Intraplantar injection of menthol produced a marked nocicep-
tion in mice. Previous treatment with the general TRP blocker
ruthenium red (3mg/kg, i.p.) reduced nociception evoked by men-
thol in 51±7% (P<0.05). Furthermore,myricitrin (1–30mg/kg, i.p.)
inhibited (95±3%)menthol-inducednociceptive behaviorwith the
mean ID50 value of 2.4 (1.5–3.7)mg/kg (Fig. 2A). Post hoc compar-
isons with the Newman–Keuls test detected signiﬁcant differences
with myricitrin treatment at doses of 10mg/kg (P<0.001) and
30mg/kg (P<0.001). A time-course analysis of the antinocicep-
tive effect of myricitrin is shown in Fig. 2B. Myricitrin produced
marked antinociception as early as 15min after administration, an
action that remained signiﬁcant up to 60min (Fig. 2B). Further-
more, menthol promoted mechanical and cold allodynia, lasting 2
and 4h, respectively. Myricitrin (30 and 100mg/kg, i.p.) reduced
M.M. Córdova et al. / Neuroscience Letters 495 (2011) 173–177 175
Fig. 1. Effect produced by intraperitoneal administration of myricitrin (3–100mg/kg, i.p.) on bradykinin (3nmol/paw, panel A)-, prostaglandin E2 (3nmol/paw, panel B)-,
cinnamaldehyde (10nmol/paw, panel C)- or acidiﬁed saline (pH 5/paw, panel D)-induced nociception in mice. Mice were treated with myricitrin, vehicle (C, 10ml/kg; i.p.),
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mamphor (7.6mg/kg, s.c.) or amiloride (100mg/kg, i.p.) 30min prior to the i.pl. injec
nimals (n) indicated in each group shown in the ﬁgure panels. Signiﬁcance levels w
NOVA followed by Newman–Keuls’ test).
enthol-induced mechanical allodynia at 30 (P<0.05 and 0.001),
0 (P<0.001 and 0.01) and 120 (P<0.01 for 100mg/kg)min after
yricitrin treatment (Fig. 2C). However, the highest dose of myric-
trin (100mg/kg) reduced menthol evoked cold allodynia at 60min
P<0.05) (Fig. 2D).
Studies have reported that ﬂavonoids exert antioxidant,
nti-inﬂammatory, immunomodulatory, antiallergic, neuroprotec-
ive, anti-mutagenic, anti-rheumatic and antinociceptive effects
8,9,25]. We have demonstrated that myricitrin reduced both
cute and chronic pain in mice. The antinociceptive action of this
avonoid has been attributed to inhibition of protein kinase C acti-
ation, NO production and anti-inﬂammatory activity [2,14,25,26].
his study extends and conﬁrms previous reports that myric-
trin displays potent antinociceptive properties against nociception
aused by bradykinin, acidiﬁed saline and TRPs channels agonists
nto the mouse hind paw. It is well established that bradykinin
articipates in the processes of nociceptor excitation and sensiti-
ation to other noxious or even innocuous stimuli through binding
f speciﬁc G-protein-coupled kinin B2 receptors and by a direct
ctivation of PKC- and an indirect activation of the PKA-signaling
athways [7,12]. In agreement with previous data [12], bradykinin
njection into the hind paw caused a rapid and marked overt
ociception in mice. The results shown here reveal that myric-
trin abolished bradykinin-induced nociception. Additionally, it
as reported that mechanical hyperalgesia induced by i.pl. injec-
ion of bradykinin in rats was reduced by myricitrin, an effect that
eems to involve the activation of PKC [25]. Thus, the effect of the
yricitrin against bradykinin-induced nociception and mechani-f respective algogens. Each column represents the mean± S.E.M. of the number of
ompared to the control group are indicated by **P<0.01 and ***P<0.001 (one way
cal hyperalgesia might explain, at least partially, the ability of this
ﬂavonoid to interact with the PKC pathway.
Furthermore, bradykinin may also exert indirect effects on the
nociceptive process, such as generating phospholipase A2 lipid
mediators, namely prostaglandins and leukotrienes [7,38]. To date,
prostaglandin E2-induced hind paw nociception in mice is medi-
ated through activation of speciﬁc G-protein-coupled EP3 and EP4
receptors, with the involvement of both PKA and ERK signaling
pathways [19]. However, treatmentwithmyricitrinwas ineffective
inattenuatingnociception (thecurrent study) and thedevelopment
of mechanical hyperalgesia [25] induced by prostaglandin E2 in
mice and rats, respectively. Our data reinforce the notion that PKA-
dependent pathway is probably not involved in the antinociception
produced by myricitrin.
Moreover, there is evidence implicating the TRPV1 and TRPA1
activation in bradykinin-induced nociception through B2 receptors
signaling in nociceptors [5,12]. Additionally, intraplantar injection
of capsaicin andallyl isothiocyanate cause acutenociceptivebehav-
iors in mice, an effect that is mediated via activation of TRPV1 and
TRPA1 receptors, respectively, reinforcing the important role of
its channels in acute nociception transmission [3,12]. It has been
reported that myricitrin reduced nociception induced by intra-
plantar injection of capsaicin, an agonist of the TRPV1 receptor
[25]. Remarkably, the present study demonstrates that myricitrin
reduced the nociceptive response caused by intraplantar injection
of cinnamaldehyde (an agonist of the TRPA1 receptor), with the
same inhibition proﬁle observed in neurogenic nociception caused
by capsaicin.
176 M.M. Córdova et al. / Neuroscience Letters 495 (2011) 173–177
Fig. 2. Effect produced by intraperitoneal administration ofmyricitrin (1–100mg/kg, i.p.) on nociception (panels A and B)-,mechanical (panel C)- and cold (panel D)-allodynia
induced by intraplantar injection ofmenthol. Panel B shows the time-course of antinociceptive effect ofmyricitrin (30mg/kg, i.p.) treatment.Mice receivedmyricitrin, vehicle
(C, 10ml/kg, i.p.) or ruthenium red (RR, 3mg/kg, i.p.) 30min before menthol injection (1.2mol/paw). Each column represents the mean± S.E.M. of the number of animals (n)
indicated in each group shown in the ﬁgure panels and each point represents the mean± S.E.M. of paw withdrawal frequency to von Frey hair stimulation or the nocifensive
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We also investigated the possible antinociceptive effect of
yricitrin against nociception induced by intraplantar injection
f acidiﬁed saline. Several studies demonstrated that protons pro-
ote direct activation of nociceptors [30,39] and hyperalgesia [37]
nd that TRPV1 and ASIC channels are proton-sensing ion chan-
els [11,20]. In fact, tissue acidiﬁcation down to pH 5 occurs in
variety of painful tissue pathologies and protons are thought to
e involved in the generation of inﬂammatory pain [34]. Impor-
antly, the nociceptive responses elicited by acidiﬁed saline were
xtensively inhibited by prior treatment with amiloride, a blocker
f ASIC channels [40].Wehave shown that previous treatmentwith
yricitrin reduced acidiﬁed saline-induced nociception in mice.
hus, the antinociceptive effect of the myricitrin against acidiﬁed
aline might be explained by the ability of this ﬂavonoid to inter-
ct with ASIC or TRPV1 channels. However, we cannot exclude
he modulation of other pH-sensing G-protein-coupled receptors
n the antinociception promoted by myricitrin in acidosis-linked
ociception [17].Previous studies indicated that menthol (an active ingredient
f peppermint) could lead to membrane depolarization and action
otential ﬁring on a subpopulation of primary afferent neurons
hrough TRPM8 receptor activation [22,29,31]. Moreover, topicalmes indicated thereafter. Signiﬁcance levels when compared to the control groups
an–Keuls’ test) and by #P<0.05 when compared to the corresponding value of the
sponding value of the vehicle +menthol groups to cold and mechanical allodynia
menthol produces an innocuous cooling sensation at low con-
centrations and a burning pain sensation at high concentrations
[15,21,41]. Here, we also demonstrate that myricitrin attenuated
the nociception, mechanical and cold allodynia induced by intra-
plantar injection of menthol. It should be pointed out that menthol
may interactwith other ion channels expressed in sensory neurons,
and that the cold sensation appears to involve potassium channels
in the transduction and modulation of temperature information
[28,35]. In this regard, it is important to mention that myricitrin-
induced antinociception also involves the opening of voltage- and
small-conductance Ca2+-gated K+ channels [24]. Another study
showed that the ﬂavonol myricetin (the non-glycosylated form
of myricitrin) reduces the ongoing mechanical allodynia and heat
hyperalgesia in response to the spinal nerve ligation in rats [16]. In
addition, it has been demonstrated, in dorsal root ganglion cultures
from normal animals, that myricetin also interferes with intracel-
lular calcium concentration through inhibition of voltage activated
Ca2+ channels in a PKC-dependent fashion, which strongly sug-
gests that this relatedﬂavonoids couldmodulate other ion channels
involved in painful conditions [16]. Nonetheless, the present data
thatmyricitrinpromotesantinociceptiveandanti-allodynic actions
after intraplantar injection ofmenthol could reﬂect amodulation of
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a2+ and/orK+ ionchannels aswell as an indirectordirect inhibition
f the PKC signaling mechanisms.
Collectively, these ﬁndings conﬁrm and largely extend results
rom literature by giving new insights about the complex
ntinociceptive proﬁle of myricitrin. In addition to well known
ntinociceptive mechanisms previously demonstrated, myricitrin
ppears modulate the activation of nociceptors by bradykinin and
RPs agonist (i.e. cinnamaldehyde, acidiﬁed saline and menthol).
urthermore, myricitrin probably could prevent the sensitization
rocess in peripheral nociceptors through inhibition of PKC signal-
ng pathways. Together, it is reasonable to propose that myricitrin
ight be of potential interest in the development of new clinically
elevant drugs for the management of pain.
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